Company News For Oct 17, 2017

Zacks Equity Research Published on October 17, 2017

Shares of Exelixis, Inc. (EXEL - Free Report) surged 17.2% after the company stated that it had received priority review status from FDA for a new drug application used in the treatment of advanced renal cell carcinoma (RCC)
Shares of Tesla, Inc. (TSLA - Free Report) declined 1.4% after the carmaker laid off a huge number of workers following their annual performance review
Sonic Corp.’s shares gained 1.7% after the company posted fourth quarter earnings per share of $0.45, surpassing the Zacks Consensus Estimate of $0.43
Badger Meter, Inc.’s (BMI - Free Report) shares dipped 1.2% after the company posted third quarter earnings of $0.27 a share, missing the Zacks Consensus Estimate of $0.35

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.